Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
LETTER TO EDITOR
Year : 2022  |  Volume : 35  |  Issue : 4  |  Page : 2087-2088

Evidence of nonpharmacological therapy for resistant hypertension


Department of Pharmacology, S.M.S. Medical College Hospital, Jaipur, Rajasthan, India

Date of Submission17-Jan-2022
Date of Decision10-Apr-2022
Date of Acceptance12-Apr-2022
Date of Web Publication04-Mar-2023

Correspondence Address:
Shivankan Kakkar
SMS Medical College Hospital, Jaipur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_26_22

Rights and Permissions

How to cite this article:
Kakkar S. Evidence of nonpharmacological therapy for resistant hypertension. Menoufia Med J 2022;35:2087-8

How to cite this URL:
Kakkar S. Evidence of nonpharmacological therapy for resistant hypertension. Menoufia Med J [serial online] 2022 [cited 2024 Mar 29];35:2087-8. Available from: http://www.mmj.eg.net/text.asp?2022/35/4/2087/371000




  Body Top


I read with great interest the article by Kamal and Hassan, treatment of resistant hypertension [1]. It was a marvelously informative article. Many medical conditions that were life-threatening in the past, nowadays, thanks to research, are treatable, either by lifestyle changes and/or medications. Cardiovascular health is something all need to be aware of, and should make efforts to minimize the risk factors over which they can have some control.

We can classify cardiovascular disease (CVD) risk factors into two groups: nonmodifiable and modifiable risk factors. The nonmodifiable such as sex, age, ethnicity, and family history of CVD, like the name, cannot be modified. So the prevention programs in this risk-factor group are mostly in raising awareness of people with these risk factors. The modifiable ones, such as unhealthy eating habits, sedentary lifestyle, smoking, and high-salt intake are the ones that can be the target of nonpharmacological therapy such as lifestyle changes. Smoking on average reduces the life expectancy of an individual by almost 10 years and also has multiple effects on our physiology that contribute to CVD [2]. In addition, medical therapy can also be prescribed to reduce the risks. Nevertheless, health education and promotion are vital for both the risk-factor groups.

People have a greater chance of developing hypertension when a cardiovascular risk is present in them. Blood-pressure measure must be monitored regularly for the right values for systolic and diastolic pressures. Low-salt diet, fruits, veggies, and little or no oil and absolute no to smoking will help bring down the blood pressure. Blood-pressure control would lead to lower chances of forming an atheroma, so less chance of developing atherosclerosis, therefore, even lesser chances of having a stroke, myocardial infarction, or deep-vein thrombosis.

I advocate the following measures in continuation to those already been addressed in the article:

  1. People with genetic CVD must follow a healthy diet pattern.
  2. People, especially belonging to the age group of 65 and above, must have exercise and diet balance for a healthy living [3].
  3. Tools such as QRISK factor and other computer programs should be used by physicians to identify cardiovascular risks in routine outpatients [4].
  4. There should be a mandate on regular public health education and promotion activities on avoiding saturated fats, stress, and smoking.


Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Kamal AM, Hassan MN. Nonpharmacological treatment of resistant hypertension: a systematic review. Menoufia Med J 2021; 34:1214.  Back to cited text no. 1
    
2.
Wirayuda AA, Chan MF. A systematic review of sociodemographic, macroeconomic, and health resources factors on life expectancy. Asia Pac J Public Health 2021; 33:335–356.  Back to cited text no. 2
    
3.
Chia CW, Egan JM, Ferrucci L. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk. Circ Res 2018; 123:886–904.  Back to cited text no. 3
    
4.
Gidlow CJ, Ellis NJ, Cowap L, Riley V, Crone D, Cottrell E, et al. A qualitative study of cardiovascular disease risk communication in NHS Health Check using different risk calculators: protocol for the RIsk COmmunication in NHS Health Check (RICO) study. BMC Fam Pract 2019; 20:11.  Back to cited text no. 4
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Body
References

 Article Access Statistics
    Viewed384    
    Printed24    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]